Day One Biopharmaceuticals OverviewDay One Biopharmaceuticals Other Income Expense Net
Other Income/Expense Net for DAWN.
Quarterly Other Income/Expense
$4.20M
↓ 30.99% YoY
As of Dec 31, 2025
Annual Other Income/Expense (TTM)
$18.45M
↓ 85.69% YoY
Trailing 12 months ending Dec 31, 2025